is ghk-cu endogenous - 200MG (Topical) GHK-Cu as a multifunctional copper

The abdomen provides consistent absorption, easy access for self-administration, and adequate fatty tissue in most individuals

Tesamorelin is an FDA-approved prescription drug (brand name Egrifta), cleared in 2010 on the strength of multiple Phase 3 double-blind, placebo-controlled randomized trials for a specific, narrow indication: reducing excess abdominal fat in people with HIV-associated lipodystrophy

By keeping GH levels elevated through natural pulsatile release, Tesamorelin could protect against the muscle loss that rapid weight reduction often triggers

This nasal spray format is used in research settings as a delivery method that allows investigators to study peptide uptake and systemic distribution without gastrointestinal degradation